questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Protéines de transport membranaire
Systèmes de transport d'acides aminés
Systèmes de transport d'acides aminés neutres
Systèmes de transport d'acides aminés neutres : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Systèmes de transport d'acides aminés neutres : Questions médicales les plus fréquentes",
"headline": "Systèmes de transport d'acides aminés neutres : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Systèmes de transport d'acides aminés neutres : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-27",
"dateModified": "2025-04-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Systèmes de transport d'acides aminés neutres"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Systèmes de transport d'acides aminés",
"url": "https://questionsmedicales.fr/mesh/D026905",
"about": {
"@type": "MedicalCondition",
"name": "Systèmes de transport d'acides aminés",
"code": {
"@type": "MedicalCode",
"code": "D026905",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.585.200"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Système A de transport d'acides aminés",
"alternateName": "Amino Acid Transport System A",
"url": "https://questionsmedicales.fr/mesh/D026924",
"about": {
"@type": "MedicalCondition",
"name": "Système A de transport d'acides aminés",
"code": {
"@type": "MedicalCode",
"code": "D026924",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.585.200.500.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Système ASC de transport d'acides aminés",
"alternateName": "Amino Acid Transport System ASC",
"url": "https://questionsmedicales.fr/mesh/D026962",
"about": {
"@type": "MedicalCondition",
"name": "Système ASC de transport d'acides aminés",
"code": {
"@type": "MedicalCode",
"code": "D026962",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.585.200.500.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Système L de transport d'acides aminés",
"alternateName": "Amino Acid Transport System L",
"url": "https://questionsmedicales.fr/mesh/D027062",
"about": {
"@type": "MedicalCondition",
"name": "Système L de transport d'acides aminés",
"code": {
"@type": "MedicalCode",
"code": "D027062",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.585.200.500.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Systèmes de transport d'acides aminés neutres",
"alternateName": "Amino Acid Transport Systems, Neutral",
"code": {
"@type": "MedicalCode",
"code": "D026921",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Stefan Bröer",
"url": "https://questionsmedicales.fr/author/Stefan%20Br%C3%B6er",
"affiliation": {
"@type": "Organization",
"name": "Research School of Biology, Australian National University, Canberra, ACT, Australia."
}
},
{
"@type": "Person",
"name": "Kiran Javed",
"url": "https://questionsmedicales.fr/author/Kiran%20Javed",
"affiliation": {
"@type": "Organization",
"name": "Research School of Biology, Australian National University, Canberra, ACT, Australia."
}
},
{
"@type": "Person",
"name": "Bowen Wu",
"url": "https://questionsmedicales.fr/author/Bowen%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Institute of Rice Industry Technology Research, Key Laboratory of Functional Agriculture of Guizhou Provincial, Department of Education, Key Laboratory of Molecular Breeding for Grain and oil Crops in Guizhou Province, College of Agricultural Sciences, Guizhou University, Guiyang, 550025, China."
}
},
{
"@type": "Person",
"name": "Zhongming Fang",
"url": "https://questionsmedicales.fr/author/Zhongming%20Fang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Rice Industry Technology Research, Key Laboratory of Functional Agriculture of Guizhou Provincial, Department of Education, Key Laboratory of Molecular Breeding for Grain and oil Crops in Guizhou Province, College of Agricultural Sciences, Guizhou University, Guiyang, 550025, China. zmfang@gzu.edu.cn."
}
},
{
"@type": "Person",
"name": "Cesare Indiveri",
"url": "https://questionsmedicales.fr/author/Cesare%20Indiveri",
"affiliation": {
"@type": "Organization",
"name": "Department of DiBEST (Biologia, Ecologia, Scienze Della Terra) Unit of Biochemistry and Molecular Biotechnology, University of Calabria, Via Bucci 4C, 87036, Arcavacata Di Rende, CS, Italy. cesare.indiveri@unical.it."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Presence of HPV in prostate tissue from patients submitted to prostate biopsy.",
"datePublished": "2023-01-13",
"url": "https://questionsmedicales.fr/article/36651430",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/acb371205"
}
},
{
"@type": "ScholarlyArticle",
"name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36253300",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clgc.2022.09.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.",
"datePublished": "2024-10-20",
"url": "https://questionsmedicales.fr/article/39428439",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-76355-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.",
"datePublished": "2023-05-26",
"url": "https://questionsmedicales.fr/article/37271051",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmpb.2023.107624"
}
},
{
"@type": "ScholarlyArticle",
"name": "Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36917412",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11255-023-03531-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de transport membranaire",
"item": "https://questionsmedicales.fr/mesh/D026901"
},
{
"@type": "ListItem",
"position": 6,
"name": "Systèmes de transport d'acides aminés",
"item": "https://questionsmedicales.fr/mesh/D026905"
},
{
"@type": "ListItem",
"position": 7,
"name": "Systèmes de transport d'acides aminés neutres",
"item": "https://questionsmedicales.fr/mesh/D026921"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Systèmes de transport d'acides aminés neutres - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Systèmes de transport d'acides aminés neutres",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Systèmes de transport d'acides aminés neutres",
"description": "Comment diagnostiquer un trouble de transport d'acides aminés ?\nQuels examens sont utilisés pour évaluer le transport d'acides aminés ?\nLes symptômes peuvent-ils indiquer un trouble de transport ?\nQuel rôle joue l'historique médical dans le diagnostic ?\nLes tests de dépistage néonatal incluent-ils ces troubles ?",
"url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Prostatic+Neoplasms&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Systèmes de transport d'acides aminés neutres",
"description": "Quels sont les symptômes d'un trouble de transport d'acides aminés ?\nLes troubles digestifs sont-ils liés à ces systèmes ?\nPeut-on observer des anomalies neurologiques ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des signes cutanés associés ?",
"url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Prostatic+Neoplasms&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Systèmes de transport d'acides aminés neutres",
"description": "Peut-on prévenir les troubles de transport d'acides aminés ?\nL'alimentation joue-t-elle un rôle préventif ?\nLes conseils génétiques sont-ils utiles ?\nLe suivi médical régulier est-il important ?\nLes vaccinations ont-elles un impact ?",
"url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Prostatic+Neoplasms&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Systèmes de transport d'acides aminés neutres",
"description": "Quels traitements sont disponibles pour ces troubles ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils aider ?\nComment un régime alimentaire peut-il aider ?\nY a-t-il des traitements expérimentaux ?",
"url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Prostatic+Neoplasms&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Systèmes de transport d'acides aminés neutres",
"description": "Quelles complications peuvent survenir ?\nLes troubles psychologiques sont-ils possibles ?\nY a-t-il des risques de maladies métaboliques ?\nLes complications peuvent-elles affecter la qualité de vie ?\nDes problèmes de croissance peuvent-ils survenir ?",
"url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Prostatic+Neoplasms&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Systèmes de transport d'acides aminés neutres",
"description": "Quels sont les facteurs de risque génétiques ?\nL'alimentation peut-elle influencer le risque ?\nLes infections peuvent-elles aggraver la situation ?\nL'âge parental joue-t-il un rôle ?\nY a-t-il des facteurs environnementaux à considérer ?",
"url": "https://questionsmedicales.fr/mesh/D026921?mesh_terms=Prostatic+Neoplasms&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble de transport d'acides aminés ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses sanguines peuvent être effectués pour évaluer le transport."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer le transport d'acides aminés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de concentration d'acides aminés dans le sang et l'urine sont courants."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils indiquer un trouble de transport ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fatigue ou des troubles de croissance peuvent alerter."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des antécédents familiaux de troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage néonatal incluent-ils ces troubles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains programmes de dépistage néonatal incluent des tests pour ces troubles."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un trouble de transport d'acides aminés ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, retard de croissance et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles digestifs sont-ils liés à ces systèmes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles digestifs peuvent survenir en raison d'une malabsorption des acides aminés."
}
},
{
"@type": "Question",
"name": "Peut-on observer des anomalies neurologiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies neurologiques peuvent se manifester en raison d'un manque d'acides aminés."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon l'âge et le type de trouble de transport."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines carences peuvent entraîner des éruptions cutanées ou des problèmes dermatologiques."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles de transport d'acides aminés ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est limitée, mais un dépistage précoce peut aider à gérer les cas."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle préventif ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut aider à prévenir certaines carences en acides aminés."
}
},
{
"@type": "Question",
"name": "Les conseils génétiques sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conseils génétiques peuvent aider les familles à comprendre les risques héréditaires."
}
},
{
"@type": "Question",
"name": "Le suivi médical régulier est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier peut aider à détecter les problèmes tôt."
}
},
{
"@type": "Question",
"name": "Les vaccinations ont-elles un impact ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations n'ont pas d'impact direct sur les troubles de transport d'acides aminés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ces troubles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des régimes alimentaires spécifiques et des suppléments d'acides aminés."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en cours d'étude pour certains troubles de transport d'acides aminés."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent améliorer l'absorption ou réduire les symptômes associés."
}
},
{
"@type": "Question",
"name": "Comment un régime alimentaire peut-il aider ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un régime adapté peut compenser les carences en acides aminés et améliorer la santé."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements expérimentaux sont en cours pour certains troubles rares."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des retards de développement et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles psychologiques sont-ils possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles psychologiques peuvent survenir en raison de carences nutritionnelles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies métaboliques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies métaboliques peuvent se développer si les troubles ne sont pas traités."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Des problèmes de croissance peuvent-ils survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes de croissance sont fréquents chez les enfants atteints de ces troubles."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque génétiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de troubles métaboliques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'alimentation peut-elle influencer le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation pauvre en acides aminés peut augmenter le risque de carences."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver la situation ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent exacerber les symptômes des troubles de transport."
}
},
{
"@type": "Question",
"name": "L'âge parental joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé des parents peut être un facteur de risque pour certaines anomalies."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains facteurs environnementaux peuvent influencer le développement de ces troubles."
}
}
]
}
]
}
Prostate cancer (PCa) is the second most frequent cancer among men in the Western population. Infections, such as the one caused by the human papillomavirus (HPV), have been shown to promote inflammat...
Prostate tissue fragments were collected by prostate biopsy and subjected to polymerase chain reaction with primers for the HPV L1 gene to identify the presence of the virus....
Among 162 patients, 10 (6.2%) had HPV and in 152 (93.8%) HPV was not identified in prostate biopsies. HPV was detected in 7/95 (7.4%) of patients with PCa, in 2/55 (3.6%) of patients without PCa, and ...
There were no significant levels of HPV L1 protein in prostate tissue. The findings suggest the absence of HPV oncogenic activity in the prostate tissue of patients with PCa....
In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals....
This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ...
It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high...
As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...
In recent observational studies, a potential link between prostatitis and prostate cancer (PCa) has been hinted at, yet the causality remains ambiguous. In our endeavor to scrutinize the conceivable c...
With emerging evidence to improve prostate cancer (PCa) screening, multiparametric magnetic prostate imaging is becoming an essential noninvasive component of the diagnostic routine. Computer-aided di...
We collected 1647 fine-grained biopsy-confirmed findings, including Gleason scores and prostatitis, to form a training dataset. In our experimental framework for lesion detection, all models utilized ...
An optimal model configuration with fine class granularity (prostatitis included) and OHE has scored the lesion-wise partial Free-Response Receiver Operating Characteristic (FROC) area under the curve...
This paper examines several configurations for model training in the biparametric MRI setup and proposes optimal value ranges. It also shows that the fine-grained class configuration, including prosta...
To assess the efficacy of 2-core prostate biopsy in advanced prostate cancer patients. This included a retrospective analysis of 12-core prostate biopsies and a prospective validation that a reduced n...
The first phase analyzed retrospective data from 12-core prostate biopsies between January 2013 and 2018. In the second phase, from January 2018 to January 2022, in a prospective setting, patients wit...
In the retrospective analysis, the number of positive cores in metastatic disease was 12 in 93 (73.8%), 11 in 14 (11.1%), and 10 in 7 (5.6%) patients. Using probability analysis, 94% of patients with ...
A 2-core biopsy is adequate in almost all patients with metastatic prostate cancer with PSA > 75, and this avoids excess complications and morbidity associated with a systematic 12-core prostate biops...
Financial toxicity (FT) is a growing concern among cancer survivors that adversely affects the quality of life and survival. Individuals diagnosed with aggressive cancers are often at a greater risk o...
PCa patients enrolled in the North Carolina-Louisiana Prostate Cancer Project (PCaP) were recontacted for long-term follow-up. The prevalence of FT in the PCaP cohort was estimated. FT was estimated u...
More than one-third of PCa patients reported experiencing FT. PCa aggressiveness was significantly independently associated with high FT; high aggressive PCa at diagnosis had more than twice the risk ...
Aggressive PCa was associated with high FT. Future studies should collect more information about the characteristics of men with high FT and identify additional risk factors of FT....
Prostate-specific membrane antigen (PSMA) hybrid imaging is a promising new technique gaining importance in the field of prostate cancer (PCa) diagnosis and treatment planning. By combining PSMA radio...
Cribriform (CBFM) pattern on prostate biopsy has been implicated as a predictor for high-risk features, potentially leading to adverse outcomes after definitive treatment. This study aims to investiga...
Patients who underwent multiparametric magnetic resonance imaging (mpMRI), combined 12-core transrectal ultrasound (TRUS) guided systematic (SB) and MRI/US fusion-guided biopsy were retrospectively qu...
Between 2015 and 2022, a total of 131 consecutive patients with CBFM pattern on prostate biopsy and pre-biopsy mpMRI were included. Clinical feature analysis included 1572 systematic biopsy cores (114...
The extent of disease for CBFM-containing tumors is difficult to capture on mpMRI. When comparing MRI lesions of similar dimensions and PIRADS scores, CBFM-containing tumors appear to have larger canc...
Purpose: Determine the time-dependent magnitude of intrafraction prostate displacement and a cutoff for the tracking decision. Methods: Nine patients with localized prostate cancer were treated with u...
Apart from other risk factors, chronic inflammation is also associated with the onset of Prostate Cancer (PCa), wherein pathogen infection and tissue microbiome dysbiosis are known to play a major rol...